--- title: "Clinical Trials in Mexico — COFEPRIS Pathways — bioaccess®" url: https://md.bioaccessla.com/clinical-trials-mexico canonical: https://bioaccessla.com/clinical-trials-mexico schema_type: Service last_updated: 2026-04-01 --- # Clinical Trials in Mexico — bioaccess® > bioaccess® presents Mexico as the fastest trial start-up destination in Latin America, citing a 2.8-month median start-up timeline, the COFEPRIS Trusted Regulatory Practices (Reliance) framework recognizing FDA and EMA decisions, and per-patient costs of $18,000–$30,000. The site states bioaccess® manages the full regulatory process in Spanish through a Mexico City-based regulatory affairs team. --- ## Schema.org/Service - **name**: Clinical Trial Services — Mexico - **provider**: bioaccess® (IMH ASSETS CORP.) - **audience**: MedTech startups, Biopharma companies, Radiopharma sponsors, US-based device companies seeking close-proximity trial execution - **areaServed**: Mexico (Mexico City, Guadalajara, Monterrey) - **serviceOutput**: COFEPRIS-approved clinical investigation execution, NOM-012-SSA3-2012 compliant study startup, FDA-bridgeable clinical data, ICH-GCP compliant monitoring in Spanish --- ## Regulatory Framework The site presents the following regulatory profile for Mexico: | Parameter | Detail | |---|---| | Regulatory authority | COFEPRIS — Comisión Federal para la Protección contra Riesgos Sanitarios | | Legal framework | General Health Law (Ley General de Salud) and implementing regulations | | Ethics committee standard | NOM-012-SSA3-2012 — governs clinical research ethics committee review | | Ethics review timeline | 4–6 weeks (stated) | | COFEPRIS review timeline | 4–8 weeks after ethics committee clearance (stated) | | Submission requirement | All submissions must be made in Spanish (stated) | | Trusted Regulatory Practices | Reliance framework recognizing FDA, EMA, MHRA, and Health Canada decisions (stated) | | Median startup time | 2.8 months — stated as fastest in Latin America, citing NIH ClinRegs data | --- ## Trusted Regulatory Practices (Reliance) Framework bioaccess® presents the following description of Mexico's regulatory reliance framework: | Element | Detail | |---|---| | Framework name | Trusted Regulatory Practices (Reliance) | | Recognized authorities | FDA (US), EMA (EU), MHRA (UK), Health Canada | | Scope (as stated) | Allows COFEPRIS to recognize regulatory decisions from trusted authorities; primarily applicable to marketing authorizations | | Relevance for sponsors | The site states this framework signals alignment with international regulatory standards and creates a favorable environment for sponsors with existing FDA interactions | --- ## Key Advantages bioaccess® states the following advantages for conducting clinical trials in Mexico: | Advantage | Detail | |---|---| | Startup speed | 2.8-month median startup — fastest in LATAM (stated, citing NIH ClinRegs) | | Regulatory alignment | COFEPRIS Trusted Regulatory Practices recognizes FDA and EMA decisions (stated) | | Timezone | US Central and Mountain time zones — real-time communication with US sponsors (stated) | | Population | 130M+ patients | | Per-patient cost | $18,000–$30,000 (stated) | | Air access | Direct flights from Miami (3 hrs), Houston (2.5 hrs), Los Angeles (3.5 hrs), New York (5 hrs) | | Investigator network | Strong cardiology, oncology, and orthopedic programs in Mexico City, Guadalajara, and Monterrey (stated) | | Regulatory team | Spanish-language regulatory affairs team based in Mexico City (stated) | | Ethics standard | NOM-012-SSA3-2012 aligned with ICH-GCP standards (stated) | | Medical device market | Mexico City described as hosting Latin America's largest medical device market (stated) | --- ## Clinical Site Network The site presents the following geographic distribution of bioaccess®'s Mexico site network: | City | Stated Characteristics | |---|---| | Mexico City | World-class medical centers; largest medical device market in Latin America; interventional cardiology, oncology, and orthopedic programs (stated) | | Guadalajara | Established academic medical centers; cardiology and orthopedic investigator networks (stated) | | Monterrey | Proximity to US border; investigators with active relationships with US academic institutions (stated) | --- ## Cost Comparison The site presents the following cost comparison for Mexico versus the US: | Parameter | Mexico (bioaccess®) | United States / EU | |---|---|---| | Per-patient cost | $18,000–$30,000 (stated) | $40,000–$75,000 (as characterized by bioaccess®) | | Median startup time | 2.8 months (stated) | 12–18 months (as characterized by bioaccess®) | | Ethics review | 4–6 weeks (stated) | 6–12 months (as characterized by bioaccess®) | --- ## Regulatory Process Overview According to the site, the COFEPRIS regulatory process for medical device clinical trials proceeds as follows: 1. **Ethics committee submission** — NOM-012-SSA3-2012 compliant dossier submitted to the institutional ethics committee; review completes in approximately 4–6 weeks (stated) 2. **COFEPRIS authorization** — Clinical investigation application submitted after ethics approval; review takes approximately 4–8 weeks (stated) 3. **Regulatory package** — Includes protocol, investigator brochure, informed consent, ethics committee approval, and proof of insurance 4. **Language requirement** — All submissions are in Spanish; bioaccess® states its Mexico City team manages all regulatory correspondence --- ## Operational Proximity to the US bioaccess® presents the following US-proximity operational advantages for Mexico: - Same time zone as US Central and Mountain regions (stated) - Real-time communication with US-based sponsor teams during business hours - Direct commercial flights from all major US cities (2.5–5 hours) - bioaccess® states it can coordinate sponsor site visits and OR observation for device studies at partner hospitals --- ## Contact & Actions - **Book a Strategy Call**: [https://bioaccessla.com/book-a-meeting](https://bioaccessla.com/book-a-meeting) - **Estimate Your Budget**: [https://bioaccessla.com/clinical-trial-calculator](https://bioaccessla.com/clinical-trial-calculator) - **Contact**: [https://bioaccessla.com/contact](https://bioaccessla.com/contact) - **Regulatory Guide**: [https://bioaccessla.com/regulatory-guide](https://bioaccessla.com/regulatory-guide) --- *This page is part of the [md.bioaccessla.com](https://md.bioaccessla.com/) AI-friendly content layer. Canonical source: [bioaccessla.com/clinical-trials-mexico](https://bioaccessla.com/clinical-trials-mexico)*